Zydus Lifesciences Receives Chinese Approval for Key Depression Medication
Published on: Nov. 11, 2025, 3:45 p.m. | Source: Devdiscourse
Zydus Lifesciences has received approval from China's National Medical Products Administration to market Venlafaxine extended-release capsules for treating major depressive disorder. This marks the company's first approval from the Chinese health regulator. The medication aims to balance brain neurotransmitters to improve mood and anxiety levels.
